Log In
Print this Print this


  Manage Alerts
Collapse Summary General Information
Company VG Life Sciences Inc.
DescriptionSynthetic peptide targeting major histocompatibility complex class II (MHCII)
Molecular Target Major histocompatibility complex class II (MHCII)
Mechanism of Action 
Therapeutic ModalityPeptide
Latest Stage of DevelopmentPreclinical
Standard IndicationHIV / AIDS
Indication DetailsTreat HIV/AIDS
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today